Nordic Capital just sold ArisGlobal to Dassault Systèmes, closing a chapter of AI-driven growth in life sciences software. The deal follows a period where ArisGlobal’s AI-powered platforms accelerated clinical trials and regulatory compliance, making it a prime target for a global player like Dassault. This is not an outlier; the Nordics are seeing a surge in AI adoption across retail, smart factories, and now life sciences, with valuations reflecting the shift from niche tools to enterprise-scale solutions. For builders, the signal is clear: vertical SaaS with embedded AI is the fastest path to exit in the Nordics right now. This week, audit your product roadmap for domain-specific AI integrations that solve compliance or efficiency bottlenecks in your sector.

researched · 3 sources

7 OctGo-to-marketreaches nearby